Patent · US Active

High affinity fully human monoclonal antibodies to interleukin-8

US8604174B2 · kind B2 · utility

25Cited by
11References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 18, 2006
Grant dateDec 10, 2013
Priority date
Expiry dateMar 28, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present embodiments are related to high-affinity antibodies directed to IL-8, methods of making and characterizing such antibodies and uses of such antibodies. Isolated polynucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions (FR's) and/or complementarity determining regions (CDR's), are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.